Credent Connect N Care Limited (CREDENT)
CREDENT delivery percentage
NSE end-of-day data for
On Fri, 16 Oct 2026, 85.71% of the CREDENT shares traded on NSE were taken to delivery, against the stock's own 20-session average of 76.35%. That is higher than usual for this stock. Turnover was only ₹57 lakh, so a handful of trades can move this figure. Volume was 0.2 times its average, well below normal.
Delivery in the last 5 sessions: 84.6% · 65.8% · 84.0% · 90.3% · 85.7%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Credent Connect N Care Limited has submitted the Scrutinizer's report and voting results for its 11th Annual General Meeting held on September 29, 2026. A total of 12,913,500 votes were polled across all three agenda items, receiving 100% unanimous approval with zero dissent. The passed resolutions include adoption of FY2026 audited financial statements, re-appointment of Director Ms. Dimple Sharma, and the appointment of M/s. R K Jagetiya & Co. as Statutory Auditors. Total shareholders as on the record date of September 04, 2026, stood at 1,176.
- All 3 ordinary resolutions approved with 100% votes in favour (12,913,500 votes polled, 0 votes against)
- Adopted FY2026 audited standalone and consolidated financial statements
- Appointed M/s. R K Jagetiya & Co. (FRN: 146264W) as Statutory Auditor of the company
- Total shareholder count as on the cut-off date of September 04, 2026, was 1,176
Credent Connect N Care Limited has announced a change in Key Managerial Personnel effective September 18, 2026. Mr. Karan Sharma has resigned from the position of Chief Financial Officer citing personal reasons, with his resignation letter dated September 17, 2026. The Board has appointed Mr. Sachin Sharma, a Chartered Accountant with over 14 years of post-qualification experience across finance and M&A, as the new CFO. The Board meeting approving these changes took place on September 18, 2026, between 05:00 PM and 05:30 PM.
- CFO Karan Sharma resigned effective September 18, 2026, citing personal reasons (letter dated September 17, 2026)
- Sachin Sharma appointed as CFO and KMP effective September 18, 2026
- Incoming CFO Sachin Sharma brings 14+ years of post-qualification experience in strategic finance, M&A, and IPO readiness
- Board meeting commenced at 05:00 PM and concluded at 05:30 PM on September 18, 2026
Credent Connect N Care Limited announced changes to its Key Managerial Personnel at its board meeting on September 18, 2026. Mr. Karan Sharma resigned from the role of Chief Financial Officer effective September 18, 2026, citing personal reasons. Mr. Sachin Sharma, a Chartered Accountant with over 14 years of post-qualification experience across strategic finance and M&A, has been appointed as the new CFO effective September 18, 2026.
- CFO Mr. Karan Sharma resigned effective September 18, 2026, citing personal reasons.
- Mr. Sachin Sharma appointed as CFO and KMP effective September 18, 2026.
- Incoming CFO Sachin Sharma brings 14+ years of post-qualification experience in strategic finance and M&A.
- Board meeting commenced at 05:00 P.M. and concluded at 05:30 P.M. on September 18, 2026.
Credent Connect N Care Limited has announced remote e-voting facilities for its upcoming 11th Annual General Meeting (AGM) through CDSL. The remote e-voting window commences on Saturday, September 26, 2026 at 9:00 AM IST and concludes on Monday, September 28, 2026 at 5:00 PM IST. The cut-off date to determine shareholder voting eligibility is Friday, September 04, 2026.
- Remote e-voting begins on Saturday, September 26, 2026 at 9:00 AM IST
- Remote e-voting concludes on Monday, September 28, 2026 at 5:00 PM IST
- Cut-off date for voting eligibility set as Friday, September 04, 2026
- Remote e-voting platform provided via CDSL for the 11th AGM
Credent Connect N Care Limited has published its Annual Report for FY2025-26 and scheduled its Annual General Meeting for September 29, 2026. For FY2025-26, the company reported consolidated revenue from operations of ₹21,416.18 lakhs, driven by Healthcare Services (43.04%), Logistics Services (25.26%), and Operations & Supply Chain Management (24.93%). As of June 30, 2026, the company operated a fleet of 97 commercial vehicles with 2,589 riders and maintained relationships with 2,530 diagnostic laboratories as of March 31, 2026.
- FY2025-26 consolidated revenue from operations stood at ₹21,416.18 lakhs
- Revenue mix led by Healthcare Services at 43.04%, Logistics at 25.26%, and Supply Chain Management at 24.93%
- Maintained relationships with 2,530 diagnostic laboratory partners nationwide as of March 31, 2026
- Fleet size stood at 97 commercial vehicles and a workforce of 2,589 riders as of June 30, 2026
- Annual General Meeting scheduled to be held on September 29, 2026
Credent Connect N Care Limited approved the Directors' Report, Annual Report, and notice convening its 11th Annual General Meeting for FY 2025-26. The Board also recommended the appointment of M/s. R K Jagetiya & Co., Chartered Accountants (FRN: 146264W), as Statutory Auditors for a 5-year term from the 11th AGM to the 16th AGM. The auditor had earlier been appointed to fill a casual vacancy caused by the resignation of the previous auditor, and the full term is now subject to shareholder approval at the upcoming AGM.
- Approved notice convening the 11th Annual General Meeting for FY 2025-26 via Video Conferencing
- Recommended appointment of M/s. R K Jagetiya & Co. (FRN: 146264W) as Statutory Auditors
- Auditor tenure proposed for 5 consecutive years from the conclusion of the 11th AGM to the 16th AGM
- Board meeting held on September 5, 2026, commencing at 05:30 PM and concluding at 06:15 PM
Credent Connect N Care Limited submitted its comprehensive investor presentation outlining its business model, FY26 financial performance, and Vision 2030 roadmap. The company reported FY26 consolidated revenue from operations of ₹214.16 Cr, with EBITDA of ₹28.46 Cr (13.29% margin) and PAT of ₹18.45 Cr (8.61% margin). Net worth stood at ₹43.79 Cr with an ROE of 61.81% and ROCE of 40.00%. Management outlined an aspiration of ~45% revenue CAGR through FY30, expanding into clinical trials, pharma, and cold-chain diagnostics.
- FY26 consolidated revenue reached ₹214.16 Cr with EBITDA of ₹28.46 Cr (13.29%) and PAT of ₹18.45 Cr (8.61%)
- Return ratios remained robust with ROE reported at 61.81% and ROCE at 40.00%
- Healthcare services (43.04%), logistics (25.26%), and operations/supply chain management (24.93%) formed the bulk of FY26 revenue
- Network spans 2,500+ associated laboratories, 6,000+ field force, and ~280 domestic corporate customers
- Vision 2030 targets ~45% revenue CAGR with sector focus spanning vaccines, IVD, cord blood, and clinical trials
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
